Stacey F Barrie, MD
Obstetrics/Gynecology · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 8
- 3 carriers
- Offices
- 2
- Since medical school
- 31 years
- Saint Louis University School of Medicine, 1995
Offices
2 locations · Washington Township Medical Foundation · 125 clinicians in this group
Hospitals listed: Washington Hospital. That is not proof they admit you there this week.
Plans that list them
8 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Barrie’s office at (510) 687-9510 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
8 of 8 plans
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$8,430
Medicare paid this office $8,430 for 67 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 22 | $1,763 | $71 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 32 | $1,526 | $48 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Who their Medicare patients are
67 Original Medicare patients in 2024. Average age 72 · Women 100% · Health risk score 0.95. Above the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 70% · Diabetes 49% · Chronic kidney disease 21% · Cancer 21%.
The office billed $29,692, Medicare allowed $11,035 and paid $8,430; for 259 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 67 | 259 | 72 | 0.95 | $29,692 | $8,430 |
| 2023 | 93 | 172 | 73 | 0.68 | $23,288 | $7,430 |
| 2022 | 73 | 172 | 74 | 0.96 | $19,775 | $7,469 |
| 2021 | 88 | 321 | 72 | 0.66 | $24,307 | $11,102 |
| 2020 | 79 | 142 | 72 | 1.09 | $21,708 | $8,769 |
| 2019 | 93 | 224 | 71 | 0.73 | $28,547 | $11,001 |
| 2018 | 63 | 162 | 72 | 0.99 | $21,157 | $6,391 |
| 2017 | 73 | 231 | 71 | 1.06 | $23,649 | $7,603 |
| 2016 | 73 | 118 | 69 | 0.90 | $22,551 | $8,322 |
| 2015 | 88 | 365 | 71 | 0.85 | $20,653 | $9,010 |
| 2014 | 92 | 272 | 72 | 0.92 | $31,252 | $10,956 |
| 2013 | 88 | 566 | 71 | 0.99 | $31,300 | $16,220 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 53 | $2,506 | $47 |
| Short return visit (20+ min) | 21 | $1,476 | $67 |
2022: 3 services
| Short return visit (20+ min) | 21 | $2,186 | $75 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 31 | $1,448 | $47 |
| Short return visit | 12 | $1,073 | $49 |
2021: 3 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 49 | $2,326 | $47 |
| Short return visit (20+ min) | 15 | $1,783 | $78 |
| New patient visit (15+ min) | 11 | $775 | $70 |
2020: 3 services
| Short return visit (20+ min) | 32 | $3,114 | $65 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 30 | $1,443 | $48 |
| Urinalysis, manual test | 13 | $45 | $3 |
2019: 5 services
| Short return visit (20+ min) | 24 | $2,348 | $65 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 43 | $2,011 | $47 |
| Return visit (30+ min) | 12 | $1,343 | $96 |
| New patient visit (30+ min) | 13 | $1,142 | $88 |
| Urinalysis, manual test | 19 | $68 | $3 |
2018: 2 services
| Short return visit (20+ min) | 29 | $2,114 | $53 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 27 | $1,213 | $45 |
2017: 3 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 41 | $1,825 | $45 |
| Short return visit (20+ min) | 15 | $1,410 | $64 |
| Return visit (30+ min) | 13 | $1,305 | $82 |
2016: 4 services
| Short return visit (20+ min) | 20 | $1,762 | $52 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 31 | $1,288 | $42 |
| Return visit (30+ min) | 11 | $1,016 | $85 |
| New patient visit (30+ min) | 11 | $859 | $78 |
2015: 4 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 37 | $1,578 | $43 |
| Return visit (30+ min) | 12 | $1,093 | $91 |
| Short return visit (20+ min) | 19 | $1,032 | $43 |
| Urinalysis, manual test | 12 | $41 | $3 |
2014: 3 services
| Short return visit (20+ min) | 67 | $4,305 | $56 |
| Short return visit | 12 | $435 | $36 |
| Urinalysis, manual test | 21 | $72 | $3 |
2013: 4 services
| Short return visit (20+ min) | 22 | $1,803 | $56 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 40 | $1,736 | $43 |
| Return visit (30+ min) | 11 | $1,047 | $95 |
| Urinalysis, manual test | 13 | $48 | $3 |
Drugs they prescribed that Part D paid
$9,891
Pharmacies billed $9,891 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 76) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
62 generic and 14 brand-name prescriptions · $9,891 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Premarin | 11 | $5,361 | $487 |
| Estradiol | 11 | $583 | $53 |
| Valacyclovir | 11 | $340 | $31 |
| Clotrimazole-Betamethasone | 14 | $310 | $22 |
Year by year
| 2024 | 76 | 34 | 0% (0) | 18% | $9,891 |
| 2023 | 78 | 37 | 0% (0) | 23% | $12,887 |
| 2022 | 51 | 26 | 0% (0) | 27% | $9,148 |
| 2021 | 39 | 27 | 0% (0) | None | $5,979 |
| 2020 | 66 | 39 | 0% (0) | None | $12,752 |
| 2019 | 49 | 25 | 0% (0) | None | $9,097 |
| 2018 | 48 | 28 | None | 23% | $7,705 |
| 2017 | 101 | 41 | 0% (0) | 30% | $11,267 |
| 2016 | 66 | 26 | 0% (0) | 32% | $5,858 |
| 2015 | 42 | 18 | 0% (0) | 43% | $5,042 |
| 2014 | 74 | 22 | None | 36% | $7,549 |
| 2013 | 103 | 31 | None | 33% | $10,913 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Premarin | 12 | $5,418 | $452 |
| Estradiol | 13 | $1,531 | $118 |
2019: 1 drug
| Estradiol | 11 | $3,484 | $317 |
2017: 3 drugs
| Premarin | 14 | $5,480 | $391 |
| Progesterone | 13 | $619 | $48 |
| Oxybutynin Chloride Er | 13 | $510 | $39 |
2016: 1 drug
| Falmina | 11 | $279 | $25 |
2014: 1 drug
| Sertraline | 12 | $72 | $6 |
2013: 2 drugs
| Vagifem | 16 | $2,163 | $135 |
| Estradiol | 12 | $57 | $5 |
Money from drug and device companies
$27 in 2025
| 2025 | 1 | 1 | None | $27 |
| 2024 | 1 | 1 | None | $25 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Abrysvo | $27 | 1 payment
|
See the published payment
| Pfizer | Meals · 2025-08-21 | Abrysvo | $27 |
See earlier years (2024)
2024: $25
| Hologic Sales and Service | Acessa Provu System | $25 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 86.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1841268646
- Licence
- CA A061094
- Trained
- Saint Louis University School of Medicine, 1995 · 31 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA GR0094770
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 2299 Mowry Avenue, Suite 3a, Fremont, CA, 94538
- NPI first listed
- 2006-03-09
- NPI last updated
- 2012-05-03
This is when the NPI record was last certified, not a medical board exam.